These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3021610)

  • 21. Effects of the phosphodiesterase-IV inhibitor EMD 95832/3 on tumour growth and cachexia in rats bearing the Yoshida AH-130 ascites hepatoma.
    Meijsing B; Carbó N; López-Soriano FJ; Argilés JM
    Cancer Lett; 2002 Dec; 188(1-2):53-8. PubMed ID: 12406548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of drugs on calmodulin and its interaction with phosphodiesterase.
    Van Belle H
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 17():557-67. PubMed ID: 6145333
    [No Abstract]   [Full Text] [Related]  

  • 23. Discriminative stimulus effects of the type-4 phosphodiesterase inhibitor rolipram in rats.
    Makhay MM; Houslay MD; O'Donnell JM
    Psychopharmacology (Berl); 2001 Nov; 158(3):297-304. PubMed ID: 11713620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Properties and characterization of low molecular weight inhibitor of calmodulin-dependent cAMP phosphodiesterase from rat liver.
    Rao RH; Palazzolo M; Sanders L; Smoake JA; Solomon SS
    Life Sci; 1984 Nov; 35(21):2155-64. PubMed ID: 6092816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is phosphorylation involved in the action of insulin on cyclic AMP phosphodiesterase in fat cells?
    Tokumitsu Y; Kono T
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():177-84. PubMed ID: 6326522
    [No Abstract]   [Full Text] [Related]  

  • 26. Dual regulation of tumor necrosis factor-alpha-induced CCL2/monocyte chemoattractant protein-1 expression in vascular smooth muscle cells by nuclear factor-kappaB and activator protein-1: modulation by type III phosphodiesterase inhibition.
    Chen YM; Chiang WC; Lin SL; Wu KD; Tsai TJ; Hsieh BS
    J Pharmacol Exp Ther; 2004 Jun; 309(3):978-86. PubMed ID: 14978197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tyrosine kinase-independent inhibition of cyclic-AMP phosphodiesterase by genistein and tyrphostin 51.
    Nichols MR; Morimoto BH
    Arch Biochem Biophys; 1999 Jun; 366(2):224-30. PubMed ID: 10356287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective inhibitors of calmodulin-dependent phosphodiesterase and other enzymes.
    Hidaka H; Inagaki M; Nishikawa M; Tanaka T
    Methods Enzymol; 1988; 159():652-60. PubMed ID: 2842626
    [No Abstract]   [Full Text] [Related]  

  • 29. Inhibitory effects of psoralens on rat liver cyclic AMP phosphodiesterase.
    Bovalini L; Lusini P; Simoni S; Vedaldi D; Andreassi L; Dall'Acqua F; Martelli P
    Biochem Int; 1988 Jun; 16(6):991-8. PubMed ID: 2845992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Control of low Km cyclic adenosine 3',5'-monophosphate-phosphodiesterase in prostate and heart of adult and aged rats.
    Moses MA; Szabo EI; Terner C
    Mech Ageing Dev; 1987 Jul; 39(2):103-12. PubMed ID: 3041130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Submitochondrial localization and asymmetric disposition of two peripheral cyclic nucleotide phosphodiesterases.
    Cercek B; Houslay MD
    Biochem J; 1982 Oct; 207(1):123-32. PubMed ID: 6295362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of calmodulin in insulin secretion: the presence of a calmodulin-stimulatable phosphodiesterase in pancreatic islets of normal and pregnant rats.
    Lipson LG; Oldham SB
    Life Sci; 1983 Feb; 32(7):775-80. PubMed ID: 6298548
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of streptozotocin-induced diabetes on calmodulin and cyclic AMP phosphodiesterase activity in rat lungs.
    Ofulue AF; Nijjar MS
    Lung; 1982; 160(6):303-10. PubMed ID: 6292588
    [No Abstract]   [Full Text] [Related]  

  • 34. Calmodulin in porcine malignant hyperpyrexia.
    Collins SP; White MD; Denborough MA
    Int J Biochem; 1987; 19(1):63-70. PubMed ID: 3032704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteolytic activation and solubilization of endoplasmic-reticulum cyclic AMP phosphodiesterase activity.
    Wilson SR; Houslay MD
    Biochem J; 1983 Jul; 213(1):99-105. PubMed ID: 6311162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of phosphodiesterase activity of human spermatozoa by spermine.
    Shah GV; Sheth AR
    Experientia; 1978 Aug; 34(8):980-1. PubMed ID: 212292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of cyclic AMP phosphodiesterase by flavonoids.
    Nikaido T; Ohmoto T; Sankawa U; Hamanaka T; Totsuka K
    Planta Med; 1982 Nov; 46(3):162-6. PubMed ID: 6294714
    [No Abstract]   [Full Text] [Related]  

  • 38. Inhibition of anterior pituitary cyclic AMP phosphodiesterase by colchicine and vinblastine.
    Ewart RB
    FEBS Lett; 1982 May; 141(1):25-8. PubMed ID: 6282647
    [No Abstract]   [Full Text] [Related]  

  • 39. Inhibitory effect of some flavonoids and falvonoid mixtures on cyclic AMP phosphodiesterase activity of rat heart.
    Petkov E; Nikolov N; Uzunov P
    Planta Med; 1981 Oct; 43(2):183-6. PubMed ID: 6273955
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of vinca alkaloids on calcium-calmodulin regulated cyclic adenosine 3' ,5'-monophosphatase phosphodiesterase activity from brain.
    Watanabe K; Williams EF; Law JS; West WL
    Biochem Pharmacol; 1981 Feb; 30(4):335-40. PubMed ID: 6260119
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.